Another study by Oweida et al. showed that response to anti-PD-L1 mAb and radiotherapy was compensated by the increased expression of TIM-3 on CD8+ T cells and Tregs, associated with tumor relapse, poor survival rate in a mouse model of head and neck tumor (118). Here, HAVCR2 is linked to neoplasm.